Clinical Trial Update: Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating raltegravir for nonoccupational postexposure prophylaxis in men who have sex with men has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Andrew Carr | Conditions: HIV Prevention, HIV Infections | Phase 4 | Status: COMPLETED